Back to Search Start Over

Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats

Authors :
M. Zanisi
Lina Puglisi
Raffaella Ruzza
Claude Zaarour
Elio Messi
Chiara Bolego
Andrea Cignarella
Source :
Life Sciences. 60:2291-2302
Publication Year :
1997
Publisher :
Elsevier BV, 1997.

Abstract

In an attempt to study the mechanisms by which estrogens affect vascular responses, we utilized aortic preparations from intact and ovariectomized female rats receiving low- and high-dose subcutaneous estrogen treatments. Oil-treated, as well as male rats, served as controls. In ovariectomized females, low-dose 17-beta-estradiol injections (5 microg/kg daily for two days) affected the basal release of nitric oxide, as evaluated by concentration-related curves to superoxide dismutase and N(G)-Methyl-L-arginine acetate, which was found to be greater in 17-beta-estradiol-treated females compared to oil-treated females or males. Conversely, the nitric oxide-related vascular relaxation evoked by acetylcholine and sodium nitroprusside was unchanged. Prostacyclin production was also evaluated. Aortic rings from ovariectomized 17-beta-estradiol-treated females released significantly more prostacyclin than those from oil-treated females. These results point out a possible role for nitric oxide and prostacyclin in the vascular protection brought about by physiological levels of estrogens. When intact females were treated with high doses of ethynilestradiol (100 microg/Kg daily for one month), a component of contraceptive pills, either the basal release of nitric oxide, or acetylcholine-induced relaxation underwent a significant decrease. Likewise, the relaxant responses to sodium nitroprusside were impaired in the aortic rings obtained from ethynilestradiol-treated animals when compared to controls. Similarly, the amount of prostacyclin released from aortic tissues obtained from ethynilestradiol-treated animals was significantly reduced. These results may provide a possible explanation for the higher incidence of cardiovascular disease in women who take contraceptive preparations containing high doses of estrogens.

Details

ISSN :
00243205
Volume :
60
Database :
OpenAIRE
Journal :
Life Sciences
Accession number :
edsair.doi.dedup.....b68cfd191b82db6143c1097fa5f344a0
Full Text :
https://doi.org/10.1016/s0024-3205(97)00284-1